Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
12/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,439 | $24,568 | $86,706 | $0 |
| - Cash | $10,882 | $596 | $877 | $500 |
| + Debt | $10,586 | $1,865 | $500 | $500 |
| Enterprise Value | $34,143 | $25,838 | $86,329 | -$0 |
| Revenue | $21,859 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Gross Profit | $14,587 | -$60 | -$60 | – |
| % Margin | 66.7% | – | – | – |
| EBITDA | -$2,103 | -$3,992 | -$350 | – |
| % Margin | -9.6% | – | – | – |
| Net Income | -$8,795 | -$400 | -$358 | – |
| % Margin | -40.2% | – | – | – |
| EPS Diluted | -0.76 | -0.04 | -0.041 | – |
| % Growth | -1,800% | 2.4% | – | – |
| Operating Cash Flow | -$3,996 | -$1,036 | -$698 | – |
| Capital Expenditures | -$36 | $0 | $0 | – |
| Free Cash Flow | -$4,032 | -$1,036 | -$698 | – |